NCT04761549 3D, Dynamic and Mechanically-informed Decision Making in AIS
| NCT ID | NCT04761549 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Adolescent Idiopathic Scoliosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-01-19 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2021-01-19 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adolescent Idiopathic Scoliosis (AIS) is a growth defect of the spine that primarily occurs in prepubertal children between the age of 10 to 14 years, affecting approximately 3% of these otherwise normal children. AIS has been associated with problems related to posture, load-related back pain, as well as aesthetic problems, e.g. the induced asymmetry of the shoulder. Therefore, early diagnosis followed by the appropriate treatment is vital to prevent further curve progression of AIS and minimize the health-related complications of these patients. The current treatment recommendation to stop curve progression for an immature patient with a scoliosis curve between 25 and 40 degrees is to wear a brace. If the curve in the skeletally immature patient is not responding to the brace treatment, dynamic scoliosis correction by vertebral body tethering can be considered when there is still some growth potential left. State-of-the-art guidelines for the selection of fusion levels are currently mainly based on two-dimensional (2D) static radiographic parameters (such as, the Cobb angle and Shoulder balance) and a qualitative assessment of 2D bending or traction radiographs. Several classification systems and algorithms that are based on the 2D static radiographic (X-ray) parameters exist to assist surgeons in determining the appropriate levels to be instrumented. Despite this wide range of classification systems and detailed guidelines available in the literature, spinal fusion does not always yield satisfying 2D radiographic clinical outcome, with revision rates ranging from 3.9% to 22%. Overall, the surgeon is presently not provided with 3D dynamic and mechanical information regarding the deformity of the AIS to guide the decision-making. Obtaining this vital 3D dynamic information regarding the curvature and mechanical behavior of the spine will allow the surgeon to make an evidence-based and well-informed decisions in the treatment of the AIS patient. Consequently, realizing these objectives has the potential to improve patient satisfaction, reduce the postoperative complications and accordingly reduce socio-economic costs associated with AIS treatment. Recent advances in the use of subject specific musculoskeletal models will form the basis to realize this shift from 2D to 3D dynamic in AIS care.
Eligibility Criteria
Inclusion Criteria: * Patient diagnosed with Adolescent Idiopathic Scoliosis * 10-35 years old * Patient is scheduled to be surgically treated by vertebral body tethering (VBT) or selective fusion at UZ Leuven * Informed consent obtained: also from parent/guardian in case of minors Exclusion Criteria: * Patient has undergone a fusion or VBT procedure before * Patient has a severe underlying illness which might influence the outcome of the surgery * Making it reasonable for the investigator to exclude the patient
Contact & Investigator
Sebastiaan Schelfaut
PRINCIPAL INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Frequently Asked Questions
Who can join the NCT04761549 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, studying Adolescent Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04761549 currently recruiting?
Yes, NCT04761549 is actively recruiting participants. Contact the research team at sebastiaan.schelfaut@uzleuven.be for enrollment information.
Where is the NCT04761549 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT04761549 clinical trial?
NCT04761549 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Sebastiaan Schelfaut at Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 100 participants.